Conclusions
The previously reported association of low levels of on-treatment LDL-C and incident cancer, confirmed here, is not driven by statins, and statin therapy, despite producing marked reductions in LDL-C, is not associated with an increased risk of cancer. Further studies are needed to validate these findings, particularly with longer durations of follow-up.
Mas...
lunes, 25 de agosto de 2008
Sin relación uso de statinas y riesgo de cancer
Etiquetas:
Investigación,
USA
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario